What is BioCryst Pharmaceuticals's net debt?

BioCryst Pharmaceuticals (BCRX) reported net debt of $238.44M in Q1 2026.

How has BioCryst Pharmaceuticals's net debt changed year-over-year?

BioCryst Pharmaceuticals's net debt increased by 6.8% year-over-year, from $223.29M to $238.44M.

What is the long-term trend for BioCryst Pharmaceuticals's net debt?

Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's net debt has grown at a -11.2% compound annual growth rate (CAGR), from -$142.29M to -$78.38M.

What does net debt mean?

Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.

BioCryst Pharmaceuticals BCRX Net debt

Discontinued — last reported Q1 '26

Net debt at other companies

Sonos, Inc.SONO

-0.4×—

ANI PharmaceuticalsANIP

-0×-2.5×

Global Net LeaseGNL

-0.2×-0.1×

Healthcare Services GroupHCSG

-1.3×-22.6×

Global PartnersGLP

1.7×+0.2×

Ivanhoe ElectricIE

-19.6×—

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Calculated from BioCryst Pharmaceuticals’s reported figures.

$411.8Mtotal debt−$173.4Mcash and equivalents=$238.44M

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's net debt?: BioCryst Pharmaceuticals (BCRX) reported net debt of $238.44M in Q1 2026.
How has BioCryst Pharmaceuticals's net debt changed year-over-year?: BioCryst Pharmaceuticals's net debt increased by 6.8% year-over-year, from $223.29M to $238.44M.
What is the long-term trend for BioCryst Pharmaceuticals's net debt?: Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's net debt has grown at a -11.2% compound annual growth rate (CAGR), from -$142.29M to -$78.38M.
What does net debt mean?: Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.